Amexdrug AXRX · USD

Its shares trade under the ticker AXRX. It has been listed since 21 July 1972. In the fiscal year to 31 December 2024, it reported revenue of $3.4m and net income of $11,436. At that date it held total assets of $2.5m and shareholders' equity of $1.8m.

Amexdrug Corp. engages in the business of pharmaceutical, medical and cosmeceutical industry. The company is headquartered in Beverly Hills, California. The firm specializes in the research and development, manufacturing and distribution of pharmaceutical drugs, cosmetics and distribution of prescription and over-the-counter (OTC) drugs, and private manufacturing and labeling. The company operates through two segments: Distribution, and Health and Beauty Products. The Distribution segment consists of the wholesale pharmaceutical distribution and resale of brand and generic pharmaceutical products, OTC drugs and non-drug products, and health and beauty products. The Health and Beauty Products segment consists of the manufacture and distribution of primarily health and beauty products. The company distributes products to independent pharmacies, small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers. Its subsidiaries include BioRx Pharmaceuticals, Inc., Allied Med, Inc., Dermagen, Inc. and Royal Health Care Company.

Figures and description from our data supplier, not checked against the company's own report.

• Jack AminPresident, Secretary, Treasurer, Director, since 2000$154,800
• Dr. Rodney BarronIndependent Director
• Behrooz MeimandIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.